All Clinical Resources

37 - 48 of 235 results

FAQ for Current Approaches to Stroke Prevention in Atrial Fibrillation

Failure to prescribe anticoagulation to prevent stroke in high-risk atrial fibrillation (AF) patients is a persistent and pervasive problem. Despite a multitude of evidence-based clinical practice guidelines, and five effective oral anticoagulants for stroke prevention, at least 30% of these patients remain unprotected. This talk will focus on understanding the root causes of the failure to prevent stroke crisis. The role of antithrombotic therapy, in particular direct oral anticoagulants, will be reviewed. Strategies for implementation of best practices for stoke prevention in AF will be highlighted.Guest: Gregory Piazza, MD, MS

Failure to prescribe anticoagulation to prevent stroke in high-risk atrial fibrillation (AF) patients is a persistent and pervasive problem. Despite a multitude of evidence-based clinical practice guidelines, and five effective oral anticoagulants for stroke prevention, at least 30% of these patients remain unprotected. This talk will focus on understanding the root causes of the failure to prevent stroke crisis. The role of antithrombotic therapy, in particular direct oral anticoagulants, will be reviewed. Strategies for implementation of best practices for stoke prevention in AF will be highlighted.


Identifying Patients for De-escalation or Withdrawal of Inhaled Corticosteroids (ICS) in COPD

Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit


This talk will review the pathophysiologic mechanisms of pain and how to best address them.


Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT.


Most physicians are consumers of commercial air travel, and half of physicians have responded to a medical emergency on an airplane. Responding to a medical problem on an aircraft is one of the purest expressions of our Hippocratic Oath but provokes anxiety in many providers because of patient populations and conditions outside our normal scope of practice and the haphazard environment of an aircraft. Medical emergencies on flights are becoming more common as air travel is more accessible, people fly greater distances in larger aircrafts, and the inflight population ages. This talk will cover the pathophysiologic stress of commercial air travel, the approach to a midair patient and common inflight emergencies, interventions that can be performed in response to a medical emergency, the equipment available on the aircraft, as well as preparatory flight strategies for physicians. We will also discuss management considerations if asked to serve in other community medical emergencies such as encountering a motor vehicle accident.


In this informative session, the speaker will help clinicians build better understandings with their patients and discuss how to make the office a more welcoming environment. Participants will walk away with culturally informed and sensitive approaches to counseling and an enhanced comprehension of the unique mental health problems faced by the LGBTQ population.


FAQ for Seasonal Influenza: When, Who, and How to Manage?

Guest: Robert H. Hopkins, Jr, MD, MACP, FAAP & Charles Vega, MD, FAAFP


Keeping up with the many new drugs approved for use in the U.S. each year is a constant challenge. However, only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk will provide a balanced evaluation of these important novel drugs and address efficacy, side effects, cost, and the impact on primary care practice.


FAQ for HIV for the Clinician in Practice

Guest: Stephen Symes, MD, FACP